Abstract
Kawasaki disease is an illness that causes vasculitis, predominantly in pediatric patients. In addition, it represents one of the most frequent causes of acquired heart disease in children around the world (especially among those in developed countries and particularly in Northeast Asia, since this pathological disorder is related with coronary arteries’ aneurysms as its most serious sequel in many cases). It should also be noted that, although progress has been made in terms of current knowledge of this pathology since 1967 (when the first reports of this clinical diagnosis were published), its pathogenesis is still debated since it is related to various immunological and genetic mechanisms still under study. However, despite the above, various therapies related to the application of immunoglobulins and certain anti-inflammatory agents are actually being used for its treatment on many occasions, the latter because it has been reported that they are relatively effective according to contemporary literature.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2022 Guillermo Andrés Bonilla Chaves, Giulliana Gutiérrez Campos, David Rodríguez Umaña, Yenifer Vargas Ocampo